Todd Alfred Carter, Chief Scientific Officer at Voyager Therapeutics, Inc. (VYGR), sold 3,967 shares at $7.47 ($30K) on 2024-02-21, disclosed to the SEC on 2024-02-22.
Open-market sale of $30k VYGR by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.68 | 602 | $5K | 15.5% |
| 2 | $7.47 | 3,365 | $25K | 84.5% |
| Total | $7.50 avg | 3,967 | $30K | 100% |
| Filing → |
| VYGR | SELL | 2026-02-11 | $14K | — | Filing → |
| VYGR | SELL | 2025-02-24 | $14K | — | Filing → |
| VYGR | SELL | 2025-02-12 | $24K | — | Filing → |